|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-24-372745 |
AP15568PU-N |
G.D.N.F//Human, Mouse, Rat/Rabbit |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
G.D.N.F |
Description
|
/ Human, Mouse, Rat/Rabbit |
Clonality
|
Mono |
Company
|
Acris Antibodies GmbH |
Application
|
Paraffin Sections |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description: Manufacturer | Acris Antibodies GmbH | Quantity | 1.0 ml | Reactivity | Human, Mouse, Rat | Presentation | Purified | Applications | Paraffin Sections | Host | Rabbit | Shipping to | Worldwide | Swiss Prot Num | P39905 | Immunogen | Synthetic peptide corresponding to aa 186-205 of human GDNF | Product Type | Antibodies | Storage | Store the antibody (undiluted) at 2 – 8 °C. Shelf life: One year from despatch. | |
Format | State: Liquid affinity purified Ig fraction | ? | Buffer System: 10 mM PBS, pH 7.4 with BSA and Sodium Azide | |
Specificity | This antibody detects G.D.N.F (aa 186-205). | Add. information | Molecular weight: 15 kDa Cellular localisation: Cytoplasmic | Application | Immunohistochemistry on paraffin sections (1:100, 10 min at RT); staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min. Positive control: Brain tumor. Hippocampus. | Background | Glial cell line-derived neurotrophic factor (GDNF) has been identified as a potent neurotrophic factor that enhances survival of midbrain dopaminergic neurons. GDNF promotes the survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake. It was suggested that GDNF may have utility in the treatment of Parkinson's disease, which is marked by progressive degeneration of midbrain dopaminergic neurons. | Concentration | 0.2 mg/ml | |
|
|
|
|